The 5th International Workshop on CAR-T (iwCAR-T) took place in Scottsdale, AZ, on 14 – 16 April, 2023, and brought... The post iwCAR-T Session I: CAR-T therapy in lymphoma and the role of bispecific antibodies appeared first on VJHemOnc.

The 16th International Workshop on Multiple Myeloma (iwMyeloma) 2023 took place in Madrid, Spain, and brought together leading clinicians and... The post iwMyeloma Session III: reaching a cure for multiple myeloma and concepts that need to be addressed appeared first on VJHemOnc.

Myeloproliferative neoplasms (MPNs) represent a heterogeneous group of diseases which remain a challenge to treat. While there have been several... The post The current role of stem cell transplantation in MPNs & how this may change with novel agents appeared first on VJHemOnc.

The 16th International Workshop on Multiple Myeloma (iwMyeloma) 2023 took place in Madrid, Spain, and brought together leading clinicians and... The post iwMyeloma Session II: the tumor microenvironment and mechanisms of resistance to targeted therapies appeared first on VJHemOnc.

The 16th International Workshop on Multiple Myeloma (iwMyeloma) 2023 took place in Madrid, Spain, and brought together leading clinicians and... The post iwMyeloma Session I: genomics of high-risk and smoldering multiple myeloma appeared first on VJHemOnc.

Allogeneic stem cell transplantation (alloSCT) remains a valuable treatment option for fit patients with acute myeloid leukemia (AML), and the... The post The important role of transplantation in AML: improving outcomes for patients & the value of pre-transplant MRD appeared first on VJHemOnc.

Although several novel agents have been implemented in the treatment of Hodgkin and non-Hodgkin lymphoma (HL; NHL), chemotherapy remains the... The post Insights into the changing role of chemotherapy in lymphoma appeared first on VJHemOnc.

Recently, the International Consensus Classification (ICC) and World Health Organization (WHO) classification systems for myelodysplastic syndromes (MDS) were updated and... The post Comparing the ICC and WHO classifications for MDS and their impact on clinical practice appeared first on VJHemOnc.

CAR-T cell therapy represents a major breakthrough in the treatment of hematological malignancies, including multiple myeloma, non-Hodgkin lymphoma (NHL), and... The post Managing and treating toxicities associated with CAR-T therapy: CRS, ICANS & infections appeared first on VJHemOnc.

Over the years, the treatment landscape of B-cell acute lymphoblastic leukemia (B-ALL) has transformed with the implementation of novel immunotherapies,... The post The growing role of immunotherapy in the treatment of ALL & moving away from stem cell transplantation appeared first on VJHemOnc.

In recent years, novel immunotherapies, including CAR-T cell therapy, have greatly improved treatment options for patients with hematological malignancies. Although CAR-T... The post The current status of CAR-T therapy in CLL and challenges in this space appeared first on VJHemOnc.

Graft-versus-host disease (GvHD) is a common complication associated with allogeneic stem cell transplantation (alloSCT), and can occur in acute and... The post Managing and treating GvHD and other post-transplant complications appeared first on VJHemOnc.

Over the last two decades, treatment approaches for multiple myeloma have significantly changed, and measurable residual disease (MRD) assessment is... The post The role of MRD in multiple myeloma appeared first on VJHemOnc.

Myelodysplastic syndromes (MDS) represent a group of heterogeneous diseases which remain a challenge to treat, and several novel therapies are... The post Novel immune therapies in MDS and challenges in this space appeared first on VJHemOnc.

The 64th American Society of Hematology (ASH) Annual Meeting and Exposition took place on December 10-13, 2022, in New Orleans, LA,... The post NHL highlights at ASH 2022: updates in MCL, the role of transplantation, and novel bispecific antibodies appeared first on VJHemOnc.

The 64th American Society of Hematology (ASH) Annual Meeting and Exposition took place on December 10-13, 2022, in New Orleans, LA,... The post MPN highlights at ASH 2022: novel agents, combinations & the role of immunotherapy appeared first on VJHemOnc.

The 64th American Society of Hematology (ASH) Annual Meeting and Exposition took place on December 10-13, 2022, in New Orleans, LA,... The post T-cell lymphoma highlights at ASH 2022: unmet needs, clinical trial updates & future outlooks appeared first on VJHemOnc.

CD47 is a cell surface protein which is overexpressed in several cancer cells and appears to play an important role... The post The importance of CD47 in MDS and other targets of interest appeared first on VJHemOnc.

The 64th American Society of Hematology (ASH) Annual Meeting and Exposition took place on December 10-13, 2022, in New Orleans, LA,... The post CLL highlights at ASH 2022: clinical trial updates, novel BTK inhibitors & combination therapy appeared first on VJHemOnc.

The 64th American Society of Hematology (ASH) Annual Meeting and Exposition took place on December 10-13, 2022, in New Orleans,... The post Myeloma highlights at ASH 2022: improving access to CAR-T therapy & future outlooks appeared first on VJHemOnc.